PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 12:05 AM ET

Sponsor Check › Person

Michael R. Henson

Related person on Form D filings · address states as listed: CA, PA, NY, TX · listed Jun 2, 2009 → May 30, 2024

14issuers
56Form D filings
2009–2024years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:56 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:56 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

Search queued. Results are added automatically; check back later or follow this page to be notified.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:56 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

0 of 32 offerings report sales commissions; 0 report finder's fees; 1 reports proceeds to related persons totalling $141,000. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Jul 31, 2026 D/A
File 021-591040
$0$0$0None listed on this filing
EDGAR ↗May 18, 2026 D/A
File 021-544883
$0$0$0None listed on this filing
EDGAR ↗May 30, 2024 D
File 021-514569
$0$0$0None listed on this filing
EDGAR ↗Feb 20, 2024 D
File 021-505552
$0$0$0None listed on this filing
EDGAR ↗Apr 28, 2023 D
File 021-480339
$0$0$0None listed on this filing
EDGAR ↗Jul 25, 2022 D/A
File 021-367197
$0$0$0None listed on this filing
EDGAR ↗Mar 9, 2022 D
File 021-436498
$0$0$0None listed on this filing
EDGAR ↗Jun 25, 2020 D
File 021-369726
$0$0$0None listed on this filing
EDGAR ↗Feb 24, 2020 D/A
File 021-359948
$0$0$0None listed on this filing
EDGAR ↗Aug 1, 2017 D
File 021-291834
$0$0$0None listed on this filing
EDGAR ↗Jul 28, 2017 D
File 021-291665
$0$0$0None listed on this filing
EDGAR ↗Apr 27, 2016 D
File 021-262134
$0$0$0None listed on this filing
EDGAR ↗Dec 31, 2015 D
File 021-254303
$0$0$0None listed on this filing
EDGAR ↗Jun 29, 2015 D
File 021-242622
$0$0$0None listed on this filing
EDGAR ↗Nov 5, 2014 D
File 021-227751
$0$0$0None listed on this filing
EDGAR ↗Apr 4, 2013 D/A
File 021-178263
$0$0$0None listed on this filing
EDGAR ↗Feb 21, 2013 D/A
File 021-184846
$0$0$0None listed on this filing
EDGAR ↗Sep 8, 2011 D
File 021-165540
$0$0$0None listed on this filing
EDGAR ↗Aug 4, 2011 D/A
File 021-161976
$0$0$0None listed on this filing
EDGAR ↗Jun 15, 2011 D
File 021-161297
$0$0$0None listed on this filing
EDGAR ↗Feb 3, 2011 D
File 021-154788
$0$0$0None listed on this filing
EDGAR ↗Dec 27, 2010 D/A
File 021-152013
$0$0$0None listed on this filing
EDGAR ↗Oct 26, 2010 D/A
File 021-148296
$0$0$0None listed on this filing
EDGAR ↗Oct 22, 2010 D
File 021-149458
$0$0$0None listed on this filing
EDGAR ↗Mar 24, 2010 D/A
File 021-109871
$0$0$0None listed on this filing
EDGAR ↗Mar 5, 2010 D/A
File 021-71274
$0$0$0None listed on this filing
EDGAR ↗Feb 26, 2010 D/A
File 021-53652
$0$0$141,000 (est.)None listed on this filing
EDGAR ↗Jan 8, 2010 D/A
File 021-80658
$0$0$0None listed on this filing
EDGAR ↗Dec 29, 2009 D
File 021-127179
$0$0$0None listed on this filing
EDGAR ↗Aug 25, 2009 D
File 021-113574
$0$0$0None listed on this filing
EDGAR ↗Jun 2, 2009 D
File 021-100605
$0$0$0None listed on this filing
EDGAR ↗Mar 13, 2009 D
File 021-86952
$0$0$0 (est.)
Funds to be used as working capital.
None listed on this filing

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗Shape Memory Medical Inc.Executive Officer, DirectorJul 31, 2026D/A$10,000,000
similar: $829,831–$9,999,998
$6,912,40016
similar: 2–15
$25,000
similar: $10,000–$54,310
EDGAR ↗Shape Memory Medical Inc.Executive Officer, DirectorJul 16, 2026D$10,000,000
similar: $829,831–$9,999,998
$6,724,90010
similar: 2–15
$49,975
similar: $10,000–$54,310
EDGAR ↗Shape Memory Medical Inc.Executive Officer, DirectorMay 18, 2026D/A$17,000,000
similar: $829,831–$9,999,998
$17,000,00044
similar: 2–15
$25,000
similar: $10,000–$54,310
EDGAR ↗Shape Memory Medical Inc.Executive Officer, DirectorOct 7, 2025D/A$15,000,000
similar: $829,831–$9,999,998
$4,353,45129
similar: 2–15
$25,000
similar: $10,000–$54,310
EDGAR ↗Shape Memory Medical Inc.Executive Officer, DirectorApr 30, 2025D$10,000,000
similar: $829,831–$9,999,998
$4,353,45129
similar: 2–15
$25,000
similar: $10,000–$54,310
EDGAR ↗VISEON, INC.DirectorMay 30, 2024D$3,000,000
similar: $1,100,015–$10,001,163
$2,552,14426
similar: 2–14
$1,545
similar: $5,000–$50,000
EDGAR ↗Shape Memory Medical Inc.Executive Officer, DirectorFeb 20, 2024D$37,832,624
similar: $829,831–$9,999,998
$30,488,49973
similar: 2–15
$24,748
similar: $10,000–$54,310
EDGAR ↗Shape Memory Medical Inc.Executive Officer, DirectorApr 28, 2023D$6,250,000
similar: $829,831–$9,999,998
$4,800,00037
similar: 2–15
$2,803
similar: $10,000–$54,310
EDGAR ↗Shape Memory Medical Inc.DirectorJul 25, 2022D/A$19,504,882
similar: $829,831–$9,999,998
$11,504,88237
similar: 2–15
$15,824
similar: $10,000–$54,310
EDGAR ↗B2M Medical, Inc.
group: Vascular
DirectorMar 9, 2022D$1,800,000
similar: $829,831–$9,999,998
$825,0002
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Vascular Dynamics, Inc.
group: Vascular
DirectorJun 25, 2020D$38,051,662
similar: $500,000–$7,000,000
$33,051,66223
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Shape Memory Medical Inc.DirectorMay 18, 2020D$11,504,882
similar: $829,831–$9,999,998
$5,752,44137
similar: 2–15
$15,824
similar: $10,000–$54,310
EDGAR ↗VISEON, INC.Executive Officer, DirectorFeb 24, 2020D/A$29,449,269
similar: $1,100,015–$10,001,163
$29,449,26954
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗VISEON, INC.Executive Officer, DirectorFeb 6, 2020D$29,449,254
similar: $1,100,015–$10,001,163
$27,573,72953
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Shape Memory Medical Inc.DirectorAug 1, 2017D$14,000,000
similar: $829,831–$9,999,998
$7,000,00115
similar: 2–15
$7,499
similar: $10,000–$54,310
EDGAR ↗Rebound Therapeutics CorpExecutive Officer, DirectorJul 28, 2017D$16,499,999
similar: $1,100,015–$10,001,163
$16,499,99949
similar: 2–14
$5,000
similar: $5,000–$50,000
EDGAR ↗Shape Memory Medical Inc.DirectorApr 27, 2016D$4,000,000
similar: $829,831–$9,999,998
$3,000,00012
similar: 2–15
$28,000
similar: $10,000–$54,310
EDGAR ↗Rebound Therapeutics CorpExecutive Officer, DirectorDec 31, 2015D$5,000,000
similar: $1,100,015–$10,001,163
$3,760,00029
similar: 2–14
$10,000
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncDirector
Chairman of the Board of Directors
Jun 29, 2015D$10,000,000
similar: $1,100,015–$10,001,163
$10,000,00054
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Vascular Dynamics, Inc.
group: Vascular
DirectorNov 5, 2014D$22,893,686
similar: $829,831–$9,999,998
$9,714,96720
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗MICARDIA CORPDirectorApr 4, 2013D/A$5,000,000
similar: $1,100,015–$10,001,163
$3,696,10517
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Interventional Spine IncDirectorFeb 21, 2013D/A$4,000,000
similar: $1,100,015–$10,001,163
$3,440,85751
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗MICARDIA CORPDirectorFeb 5, 2013D/A$5,000,000
similar: $1,100,015–$10,001,163
$2,956,88417
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Interventional Spine IncDirectorOct 11, 2012D/A$4,000,000
similar: $1,100,015–$10,001,163
$1,700,20149
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Interventional Spine IncDirectorOct 1, 2012D$4,000,000
similar: $1,100,015–$10,001,163
$1,642,70044
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗MICARDIA CORPExecutive Officer, DirectorMay 15, 2012D$5,000,000
similar: $1,100,015–$10,001,163
$1,917,36317
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗ADVANCED CARDIAC THERAPEUTICS INC
group: Entrada
DirectorSep 8, 2011D$13,464,881
similar: $500,000–$7,000,000
$5,962,25526
similar: 2–14
$1
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorAug 4, 2011D/A$15,626,790
similar: $1,100,015–$10,001,163
$15,626,79061
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorJul 6, 2011D/A$15,007,730
similar: $1,100,015–$10,001,163
$15,006,52159
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorJun 28, 2011D$15,007,730
similar: $1,100,015–$10,001,163
$14,457,75158
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗MICARDIA CORPExecutive Officer, DirectorJun 15, 2011D$4,000,000
similar: $1,100,015–$10,001,163
$2,570,74923
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Interventional Spine IncDirectorFeb 3, 2011D$4,578,885
similar: $1,100,015–$10,001,163
$1,308,25246
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗ONSET MEDICAL CORP
group: Onset
Executive Officer, DirectorDec 27, 2010D/A$2,202,200
similar: $1,100,015–$10,001,163
$2,139,49226
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗ONSET MEDICAL CORP
group: Onset
Executive Officer, DirectorDec 16, 2010D$2,202,200
similar: $1,100,015–$10,001,163
$2,136,97725
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorOct 26, 2010D/A$2,000,000
similar: $1,100,015–$10,001,163
$1,807,71551
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗ADVANCED CARDIAC THERAPEUTICS INC
group: Entrada
DirectorOct 22, 2010D$3,200,000
similar: $500,000–$7,000,000
$1,197,94425
similar: 2–14
$1
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorOct 5, 2010D/A$2,000,000
similar: $1,100,015–$10,001,163
$1,659,89946
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorSep 29, 2010D$2,000,000
similar: $1,100,015–$10,001,163
$1,583,19343
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Reverse Medical Corp
group: Onset
Executive Officer, DirectorMar 24, 2010D/A$15,000,000
similar: $1,100,015–$10,001,163
$13,808,67722
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗MICARDIA CORPExecutive Officer, DirectorMar 5, 2010D/A$10,500,000
similar: $1,100,015–$10,001,163
$4,842,83523
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Reverse Medical Corp
group: Onset
Executive Officer, DirectorMar 2, 2010D$15,000,000
similar: $1,100,015–$10,001,163
$12,803,67721
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗ONSET MEDICAL CORP
group: Onset
Executive Officer, DirectorFeb 26, 2010D/A$12,090,140
similar: $1,100,015–$10,001,163
$3,409,73815
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗MICARDIA CORPExecutive Officer, DirectorFeb 19, 2010D$10,500,000
similar: $1,100,015–$10,001,163
$4,762,14521
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗ONSET MEDICAL CORP
group: Onset
Executive Officer, DirectorJan 26, 2010D/A$12,090,140
similar: $1,100,015–$10,001,163
$3,398,12014
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorJan 8, 2010D/A$3,000,000
similar: $1,100,015–$10,001,163
$3,000,00043
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗ADVANCED CARDIAC THERAPEUTICS INC
group: Entrada
DirectorDec 29, 2009D$5,000,000
similar: $500,000–$7,000,000
$4,642,73814
similar: 2–14
$1
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorDec 22, 2009D/A$3,000,000
similar: $1,100,015–$10,001,163
$2,886,64039
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorDec 10, 2009D/A$3,000,000
similar: $1,100,015–$10,001,163
$2,702,14134
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorNov 23, 2009D/A$3,000,000
similar: $1,100,015–$10,001,163
$2,517,14229
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗ONSET MEDICAL CORP
group: Onset
Executive Officer, DirectorNov 18, 2009D$12,090,140
similar: $1,100,015–$10,001,163
$1,248,12012
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorOct 19, 2009D/A$3,000,000
similar: $1,100,015–$10,001,163
$2,467,14128
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Ellipse Technologies IncExecutive Officer, DirectorOct 9, 2009D$3,000,000
similar: $1,100,015–$10,001,163
$1,717,14127
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Embrella Cardiovascular IncDirectorAug 25, 2009D$1,499,999
similar: $2,000,000–$19,999,994
$1,499,9992
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Reverse Medical Corp
group: Onset
Executive Officer, DirectorJul 1, 2009D$1,500,000
similar: $1,100,015–$10,001,163
$1,500,00012
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Magellan Spine Technologies Inc
group: Onset
Executive Officer, DirectorJun 2, 2009D$3,000,000
similar: $1,100,015–$10,001,163
$618,06013
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗BIOABSORBABLE THERAPEUTICS INCDirectorMar 13, 2009D$1,509,812
similar: $829,831–$9,999,998
$359,70516
similar: 2–15
No minimum reported
similar: $10,000–$54,310

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); Other Technology / 506(b) (17,390 filings); Other / 506(b) (18,678 filings); Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 40 names on the same filings (0 management entities, 40 people)

People and management entities the issuers listed as related persons on the same Form D filings as Michael R. Henson. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.

  • Thomas Thaler — 25 shared filings (5 issuers) · role as listed: Director · also listed on 1 other issuer
  • John Kilcoyne — 19 shared filings (3 issuers) · role as listed: Director · also listed on 1 other issuer
  • Samuel Shaolian — 19 shared filings (3 issuers) · role as listed: Director
  • Nicholas Lembo — 13 shared filings (1 issuer) · role as listed: Director
  • Paul Mieyal — 13 shared filings (3 issuers) · role as listed: Director · also listed on 4 other issuers
  • Edward F. Ruppel, Jr — 12 shared filings (2 issuers) · roles as listed: Executive Officer, Director
  • Duncan Maitland — 11 shared filings (1 issuer) · roles as listed: Director, Executive Officer
  • Jeffrey J. Valko — 9 shared filings (4 issuers) · roles as listed: Executive Officer, Director
  • Blair Walker — 9 shared filings (1 issuer) · role as listed: Executive Officer
  • Walter Cuevas — 9 shared filings (2 issuers) · roles as listed: Director, Executive Officer
  • Maurice Buchbinder — 7 shared filings (2 issuers) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Carolyn M. Bruguera — 6 shared filings (1 issuer) · role as listed: Executive Officer
  • Thom Rasche — 5 shared filings (1 issuer) · role as listed: Director
  • Joseph Bishop — 5 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Aris Constantinides — 4 shared filings (2 issuers) · role as listed: Director
  • Franklin D. Brown — 4 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Ashton Hudson — 4 shared filings (1 issuer) · role as listed: Director
  • Stephen L. Wilson — 4 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Donald Rohrbaugh — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Eric Kanowsky — 3 shared filings (1 issuer) · roles as listed: Director, Executive Officer · also listed on 7 other issuers
  • John Yianni — 3 shared filings (1 issuer) · role as listed: Director
  • Benjamin Tsai — 3 shared filings (2 issuers) · role as listed: Director · also listed on 4 other issuers
  • Tracy Pearson — 3 shared filings (2 issuers) · role as listed: Executive Officer
  • Jill Tracy Pearson — 3 shared filings (1 issuer) · role as listed: Executive Officer
  • Peter Davis — 3 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Peter van der Sluis — 2 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Jon Hunt — 2 shared filings (1 issuer) · role as listed: Director
  • Paul Meiyal — 2 shared filings (1 issuer) · role as listed: Director
  • Shahram Moaddeb — 2 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Gerard Harper — 2 shared filings (1 issuer) · role as listed: Director
  • Edmund J. Roschak — 2 shared filings (2 issuers) · roles as listed: Executive Officer, Director
  • Rolf Witte — 1 shared filing (1 issuer) · role as listed: Executive Officer
  • Timothy Lenihan — 1 shared filing (1 issuer) · role as listed: Director
  • Allan Johnston — 1 shared filing (1 issuer) · role as listed: Director · also listed on 3 other issuers
  • Takehito Jimbo — 1 shared filing (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Patrick Rivelli — 1 shared filing (1 issuer) · roles as listed: Executive Officer, Director · also listed on 3 other issuers
  • Alec Piplani — 1 shared filing (1 issuer) · role as listed: Executive Officer
  • Gregory S. Young — 1 shared filing (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Bruce J. Brumfield — 1 shared filing (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • E Scott Conner — 1 shared filing (1 issuer) · role as listed: Director

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Michael R. Henson appears on a new Form D, or when a court case or SEC action is matched to them. See plans →